(19)
(11) EP 1 097 219 A2

(12)

(88) Date of publication A3:
22.06.2000

(43) Date of publication:
09.05.2001 Bulletin 2001/19

(21) Application number: 99934112.6

(22) Date of filing: 16.07.1999
(51) International Patent Classification (IPC)7C12N 15/53, C12N 9/02, C12N 5/10, A61K 48/00, C12Q 1/68, C07K 16/28
(86) International application number:
PCT/US9916/164
(87) International publication number:
WO 0004/135 (27.01.2000 Gazette 2000/04)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 16.07.1998 US 116750
16.07.1998 US 160074 P

(71) Applicant: INCYTE PHARMACEUTICALS, INC.
Palo Alto, CA 94304 (US)

(72) Inventors:
  • BANDMAN, Olga
    Mountain View, CA 94043 (US)
  • TANG, Y., Tom
    San Jose, CA 95118 (US)
  • CORLEY, Neil, C.
    Mountain View, CA 94040 (US)
  • AZIMZAI, Yalda
    Hayward, CA 94547 (US)
  • BAUGHN, Mariah, R.
    San Leandro, CA 94577 (US)

(74) Representative: Wright, Simon Mark 
J.A. Kemp & Co.14 South SquareGray's Inn
London WC1R 5LX
London WC1R 5LX (GB)

   


(54) HUMAN SCAD-RELATED MOLECULES, SCRM-1 AND SCRM-2